PERSONAL POT STORIES. As I continue to post about the issue of marijuana legalization in …

💊 While patient testimonials about cannabis use can provide valuable insights into perceived benefits and lived experiences, anecdotal accounts alone are insufficient to guide clinical decision-making or recommend cannabis as a replacement for evidence-based pharmaceuticals. The claim that cannabis universally substitutes for conventional medications conflates heterogeneous conditions, ignores substantial individual variation in drug response, and overlooks the reality that many FDA-approved medications have rigorous safety and efficacy data that cannabis currently lacks for most indications. Important confounders include selection bias in who reports positive experiences, the placebo effect, natural disease fluctuation, and publication bias toward success stories rather than harms or treatment failures. Clinicians should acknowledge patients’ cannabis use without judgment, remain curious about perceived benefits, but ground treatment recommendations in the best available evidence for each specific condition, recognizing that for some patients cannabis may have a role in a broader treatment plan while for others conventional therapies remain superior or necessary.